Products / PT-141

PT-141 labelled vial

PT-141 10 mg

The research code for bremelanotide, a cyclic peptide studied at melanocortin receptors.

CAD $55.00 / vial

Vial amount

Add to cart Ask about this product

The specifics, clearly listed.

Product details

Product reference: MRD-0125 Listed amount per vial: 10 mg Sales unit: 1 vial

Read the research in context.

The research code for bremelanotide, a cyclic peptide studied at melanocortin receptors.

  • Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction — source
  • VYLEESI — bremelanotide injection — source

Candidate-molecule or reference-product background; not verification of this supplied product.

What this doesn’t establish: Verify sequence, cyclization, stereochemistry, termini and acetate basis; do not claim selective MC4-only activity. Exact supplied identity/form, measured amount, lot-linked quality reports, purity, sterility/endotoxin, storage/stability and authorization are not established by these references.

Product documents

No verified report is available here for this item. Ask about documentation for PT-141, product reference MRD-0125.

Before you decide.

Separate research about the compound from evidence about the supplied product.

Which vial amount is shown?

This listing shows 10 mg per vial.

Does the study verify this vial?

No. Research on a compound does not establish the identity, quality, safety or effectiveness of a product sold under that name.

What should I check in a report?

Check the sample identity, batch reference, issuer, date, test methods and results. A report applies to the identified sample and tests.

What information should I request?

Ask about the exact product identity, form, specification, handling requirements and relevant batch documents before deciding.